Search concepts
|
Selected Filters
|
- 25 - 50 out of 139 results
Search results
-
Clinical Trial
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Lumsden, A. B., Le, L., Peden, E. K. & Rahimi, M.
7/27/22 → …
Project: Clinical Trial
-
-
GORE® TAG® Thoracic Branch Endoprosthesis
Chang, S., Lumsden, A. B., Peden, E. K., Rahimi, M. & Reardon, M. J.
Project: Clinical Trial
-
TEDR13002 NPS Pharmaceuticals Registry Short Bowel Syndrome
Saharia, A., Abraham, B. P. & Moore, L. W.
Project: Clinical Trial
-
Selective PET imaging of astrocytes and microglia in Alzheimer's disease
Fujita, M., Masdeu, J. C., Pascual, B. & Sangu, M.
1/19/23 → …
Project: Clinical Trial
-
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Toledo, J. B., Faridar, A., Masdeu, J. C., Nakawah, M. O. & Pascual, B.
3/12/21 → …
Project: Clinical Trial
-
MRI Guided PAD Imaging
Roy, T., Karmonik, C., Lumsden, A. B. & Peden, E. K.
11/19/20 → …
Project: Clinical Trial
-
-
Neuroimaging in AD
Masdeu, J. C., Faridar, A., Karmonik, C., Nakawah, M. O., Pascual, B., Roman, G. C., Taffet, G. & Toledo, J. B.
9/15/16 → …
Project: Clinical Trial
-
PSLOT_Radiocephalic Fistulas.
Peden, E. K., Le, L., Lumsden, A. B. & Rahimi, M.
8/12/20 → …
Project: Clinical Trial
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Madan, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
-
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Abraham, B. P., Fan, C. & Glassner, K.
2/11/19 → …
Project: Clinical Trial
-
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2/13/19 → …
Project: Clinical Trial
-
BI 1425-0003 - Phase IIa - Crohn's Study - A Phase IIa, randomised, double-blind, placebo-controlled trial to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of BI 706321 orally administered for 12 weeks in patients with Crohn`s Disease (CD) receiving ustekinumab induction treatment
Abraham, B. P., Fan, C. & Glassner, K.
10/3/22 → …
Project: Clinical Trial